Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Molecules ; 27(9)2022 Apr 19.
Artículo en Inglés | MEDLINE | ID: mdl-35565962

RESUMEN

The incorporation of dehydroamino acid or fragments of oxazole into peptide chain is accompanied by a distorted three-dimensional structure and additionally enables the introduction of non-typical side-chain substituents. Thus, such compounds could be building blocks for obtaining novel foldamers and/or artificial enzymes (artzymes). In this paper, effective synthetic procedures leading to such building blocks-tetrapeptides containing glycyldehydroalanine, glycyldehydrophenylalanine, and glycyloxazole subunits-are described. Peptides containing serine were used as substrates for their conversion into peptides containing dehydroalanine and aminomethyloxazole-4-carboxylic acid while considering possible requirements for the introduction of these fragments into long-chain peptides at the last steps of synthesis.


Asunto(s)
Alanina , Oxazoles , Alanina/análogos & derivados , Alanina/química , Oxazoles/química , Péptidos/química , Fenilalanina/análogos & derivados
2.
Biomolecules ; 10(9)2020 09 14.
Artículo en Inglés | MEDLINE | ID: mdl-32938014

RESUMEN

A library of novel phosphonic acid analogues of homophenylalanine and phenylalanine, containing fluorine and bromine atoms in the phenyl ring, have been synthesized. Their inhibitory properties against two important alanine aminopeptidases, of human (hAPN, CD13) and porcine (pAPN) origin, were evaluated. Enzymatic studies and comparison with literature data indicated the higher inhibitory potential of the homophenylalanine over phenylalanine derivatives towards both enzymes. Their inhibition constants were in the submicromolar range for hAPN and the micromolar range for pAPN, with 1-amino-3-(3-fluorophenyl) propylphosphonic acid (compound 15c) being one of the best low-molecular inhibitors of both enzymes. To the best of our knowledge, P1 homophenylalanine analogues are the most active inhibitors of the APN among phosphonic and phosphinic derivatives described in the literature. Therefore, they constitute interesting building blocks for the further design of chemically more complex inhibitors. Based on molecular modeling simulations and SAR (structure-activity relationship) analysis, the optimal architecture of enzyme-inhibitor complexes for hAPN and pAPN were determined.


Asunto(s)
Aminobutiratos/síntesis química , Antígenos CD13/antagonistas & inhibidores , Inhibidores Enzimáticos/síntesis química , Fenilalanina/síntesis química , Ácidos Fosforosos/síntesis química , Bibliotecas de Moléculas Pequeñas/síntesis química , Aminobutiratos/farmacología , Animales , Sitios de Unión , Bromo/química , Antígenos CD13/química , Antígenos CD13/metabolismo , Inhibidores Enzimáticos/farmacología , Flúor/química , Humanos , Isoenzimas/antagonistas & inhibidores , Isoenzimas/química , Isoenzimas/metabolismo , Cinética , Modelos Moleculares , Fenilalanina/análogos & derivados , Fenilalanina/farmacología , Ácidos Fosforosos/farmacología , Unión Proteica , Conformación Proteica en Hélice alfa , Conformación Proteica en Lámina beta , Dominios y Motivos de Interacción de Proteínas , Bibliotecas de Moléculas Pequeñas/farmacología , Relación Estructura-Actividad , Especificidad por Sustrato , Porcinos , Termodinámica
3.
Biomolecules ; 10(4)2020 04 09.
Artículo en Inglés | MEDLINE | ID: mdl-32283833

RESUMEN

A library of phosphonic acid analogs of phenylalanine substituted with fluorine, chlorine and trifluoromethyl moieties on the aromatic ring was synthesized and evaluated for inhibitory activity against human (hAPN) and porcine (pAPN) aminopeptidases. Fluorogenic screening indicated that these analogs are micromolar or submicromolar inhibitors, both enzymes being more active against hAPN. In order to better understand the mode of the action of the most active compounds, molecular modeling was used. It confirmed that aminophosphonic portion of the enzyme is bound nearly identically in the case of all the studied compounds, whereas the difference in activity results from the placement of aromatic side chain of an inhibitor. Interestingly, both enantiomers of the individual compounds are usually bound quite similarly.


Asunto(s)
Antígenos CD13/antagonistas & inhibidores , Ácidos Fosforosos/química , Ácidos Fosforosos/farmacología , Animales , Pruebas de Enzimas , Humanos , Modelos Moleculares , Simulación del Acoplamiento Molecular , Reproducibilidad de los Resultados , Estereoisomerismo , Porcinos
4.
Pharmaceuticals (Basel) ; 12(3)2019 Sep 17.
Artículo en Inglés | MEDLINE | ID: mdl-31533309

RESUMEN

The inhibitory activity of 14 racemic phosphonic acid analogs of phenylglycine, substituted in aromatic rings, towards porcine aminopeptidase N (pAPN) and barley seed aminopeptidase was determined experimentally. The obtained patterns of the inhibitory activity against the two enzymes were similar. The obtained data served as a basis for studying the binding modes of these inhibitors by pAPN using molecular modeling. It was found that their aminophosphonate fragments were bound in a highly uniform manner and that the difference in their affinities most likely resulted from the mode of substitution of their phenyl rings. The obtained binding modes towards pAPN were compared, with these predicted for bovine lens leucine aminopeptidase (blLAP) and tomato acidic leucine aminopeptidase (tLAPA). The performed studies indicated that the binding manner of the phenylglycine analogs to biLAP and tLAPA are significantly similar and differ slightly from that predicted for pAPN.

5.
Biochimie ; 151: 119-127, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-29890205

RESUMEN

A series of phosphonic acid analogues of phenylglycine variously substituted in phenyl ring have been synthesized and evaluated for their inhibitory activity towards potato l-phenylalanine ammonia lyase. Most of the compounds appeared to act as moderate (micromolar) inhibitors of the enzyme. Analysis of their binding performed using molecular modeling have shown that they might be bound either in active site of the enzyme or in the non-physiologic site. The latter one is located in adjoining deep site nearby the to the entrance channel for substrate into active site.


Asunto(s)
Inhibidores Enzimáticos/farmacología , Glicina/farmacología , Fenilanina Amoníaco-Liasa/antagonistas & inhibidores , Ácidos Fosforosos/química , Solanum tuberosum/enzimología , Glicina/química , Modelos Moleculares , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...